Can you have a gun if you smoke a lot of pot? Supreme Court to decide

The Supreme Court will hear on March 2 a challenge to the federal ban that bars an “unlawful user” of controlled substances from possessing firearms in the prosecution of Ali Danial Hemani, who told agents he used marijuana “about every other day” and faces a felony punishable by up to 15 years. The 5th U.S. Circuit held the ban cannot be applied to a sober person based solely on past use; the Justice Department argues a narrower “habitual” use standard and is defending the statute even as the administration pursues rescheduling of marijuana. The case could limit the statute to addicts or be decided on vagueness grounds, shaping how the Court applies its recent historical-tradition test for firearms regulations, though it is unlikely to have material market impact.

Analysis

Market structure: A Supreme Court narrowing of the federal “unlawful user” ban or DOJ rescheduling materially benefits listed cannabis plays (ETFs like MJ, MSOS and large MSOs such as TLRY, CGC) by expanding medical research, reimbursement credibility and potential retail demand; expect 10–30% upside for beaten-down small caps if rescheduling language appears within 6–12 months. Firearms manufacturers (RGR, SWBI, VSTO) see ambiguous effects—if statutes are narrowed, federal prosecutions fall (neutral-to-positive for sales); if Court upholds broad bans, targeted legal risk could compress multiples by 5–15% for smaller issuers. Ancillary sectors (compliance/legal services, lab testing firms) are likely winners either way.

Risk assessment: Tail risks include (A) Court upholds broad ban → setback for MSO valuations and investor sentiment (fast 15–25% drawdown in small-caps); (B) Court strikes law as vague → rapid regulatory patchwork and state-level compliance costs that favor large operators. Immediate catalyst: oral argument March 2 (intraday/1–2 week volatility). Short-term (3–6 months): DOJ rescheduling moves; long-term (1–3 years): doctrinal Second Amendment shifts that affect thousands of regulations. Hidden dependency: rescheduling does not automatically fix banking (280E) or interstate commerce hurdles.

Trade implications: Tactical: establish modest, event-driven exposure to MJ/MSOS (1–3% portfolio) via long-call spreads expiring 3–6 months to capture a rescheduling/reaction rally while limiting downside. Pair trade: long MJ ETF (or MSOS) vs short RGR (size 2:1) for 3–6 months to express regulatory upside in cannabis while hedging discretionary weakness in firearms. Options: buy 60–120 day ATM call spreads on MJ and 30–90 day puts on SWBI as asymmetric bets into March 2.

Contrarian angles: Consensus underestimates that rescheduling alone won’t resolve banking/280E — valuation rerating requires legislative/banking fixes, so a full-weight allocation is premature. Reaction to oral arguments will be headline-driven and likely overdone; watch for 10–20% intraday moves that create mean-reversion opportunities. Historical parallel: state legalization waves (2018–2020) show initial outsized rallies followed by structural consolidation favoring MSOs and incumbents; prioritize scale and balance-sheet strength to avoid small-cap churn.

Key Decisions for Investors

• Establish a 2% long position in the ETF MJ (ETFMG Alternative Harvest) using a 3-month ATM call spread (buy calls, sell 25% OTM calls) to limit cost; increase to 4% if DOJ formally proposes rescheduling within 90 days.
• Initiate a 1% short (or buy 3-month puts) position in RGR (Sturm, Ruger & Co., ticker RGR) sized half of the MJ exposure (2:1 long MJ : short RGR) to capture relative upside in cannabis vs firearms over 3–6 months; cover if RGR drops >20% or MJ rises >30%.
• Purchase a 0.5–1% portfolio hedge: 60–90 day ATM puts on SWBI (Smith & Wesson Brands) to protect against an adverse Supreme Court ruling that upholds broad federal prohibitions; cap loss at premium paid and reassess 2 weeks after Mar 2 oral arguments.
• If the Supreme Court rules in favor of Hemani or DOJ rescinds Schedule I designation within 6 months, increase MSO exposure (TLRY, CGC) by an additional 2–3% and rotate out 50% of small-cap cannabis names into cash/further-consolidation candidates to favor balance-sheet strong operators.
• Set automated alerts: (A) March 2 oral-argument transcripts and intraday vol spikes >30% in MJ/TLRY/CGC; (B) DOJ rescheduling notices within 90 days; act on these triggers within 48 hours to enter/trim positions as outlined above.